Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of PSMA PET Imaging in Surveillance Post-Focal Therapy for Prostate Cancer (PSMA-FT Surveillance Study)

NCT07115914 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT07115914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07115914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of PSMA PET Imaging in Surveillance Post-Focal Therapy for Prostate Cancer (PSMA-FT Surveillance Study)
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Recruiting
Start date
November 19, 2025
Completion date
August 1, 2028
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (adenocarcinoma), prostate cancer (diagnosis), prostate cancer metastatic disease